Feeding Hope for a Future Free from Breast Cancer
Could you imagine being diagnosed with aggressive breast cancer? Once diagnosed imagine being then told there are no targeted treatments available to you.
That’s the case for 15 per cent of women who are diagnosed with triple negative breast cancer. Now thanks to your support of The Longest Table, researchers in Adelaide are leading the charge for a new treatment for this aggressive breast cancer type.
Pioneering this lifesaving research is Associate Professor Claudine Bonder, Professor Angel Lopez and their teams at the Centre for Cancer Biology based at the University of South Australia’s Cancer Research Institute in Adelaide.
A/Prof Bonder and the team have identified a blood hormone that helps breast cancer grow and spread using blood vessels.
“We’ve identified a growth hormone that is quite specific to patients with this aggressive breast cancer. We’re now working towards finding an identifier for this growth hormone which could act as a good target for a treatment,” A/Prof Bonder said.
This could lead to an alternative treatment to chemotherapy and radiotherapy which could save lives.
“At the moment these patient’s only treatment option is chemotherapy so our research could lead to an alternative treatment or combine a new therapy with a lower dose of chemotherapy.
“By understanding how this blood hormone contributes to breast cancer growth, we hope to identify a distinct subgroup of breast cancer patients, diagnose them earlier and one day come up with a specific or personalised treatment for them.”